Showing results (31-40 of 56) with videos related to
Sort By:
Pageof 6
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 15, 2022
Clinical outcomes of no stenting in patients with ST-segment elevation myocardial infarction undergoing deferred primary percutaneous coronary interventionJasmine Melissa Madsen, Henning Kelbæk, Lars Nepper-Christensen, et al.International Journal of Cardiology|May 13, 2019
Unreported exclusion and sampling bias in interpretation of randomized controlled trials in patients with STEMIPeter Nørkjær Laursen, Lene Holmvang, Jacob Lønborg, et al.Journal of Hypertension|November 17, 2020
Invasive aortic pulse pressure is not superior to cuff pulse pressure in cardiovascular risk predictionEsben Laugesen, Søren T Knudsen, Klavs W Hansen, et al.Lancet (London, England)|September 9, 2015
Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trialThomas Engstrøm, Henning Kelbæk, Steffen Helqvist, et al.The American Journal of Cardiology|July 8, 2019
Everolimus-Eluting Versus Biolimus-Eluting Coronary Stent Implantation in Patients With and Without Diabetes MellitusChristine Gyldenkerne, Kevin K W Olesen, Lisette O Jensen, et al.Circulation. Cardiovascular Interventions|April 14, 2017
Fractional Flow Reserve-Guided Complete Revascularization Improves the Prognosis in Patients With ST-Segment-Elevation Myocardial Infarction and Severe Nonculprit Disease: A DANAMI 3-PRIMULTI Substudy (Primary PCI in Patients With ST-Elevation Myocardial Infarction and Multivessel Disease: Treatment of Culprit Lesion Only or Complete Revascularization)Jacob Lønborg, Thomas Engstrøm, Henning Kelbæk, et al.Journal of the American College of Cardiology|May 20, 2025
10-Year Outcome of Complete or Infarct-Artery-Only Revascularization in STEMI with Multivessel Disease (DANAMI-3-PRIMULTI)Jasmine M Marquard, Rasmus P Beske, Henning Kelbæk, et al.The American Journal of Cardiology|October 4, 2025
Impact of Diabetes Mellitus on 5-year Outcomes After PCI with a Polymer-Free Drug-Coated Stent or a Biodegradable Polymer Ultra-Thin Strut StentKirstine Nørregaard Hansen, Evald Høj Christiansen, Julia Ellert-Gregersen, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 15, 2022
Impact of acute coronary syndrome on clinical outcomes after revascularization with the dual-therapy CD34 antibody-covered sirolimus-eluting Combo stent and the sirolimus-eluting Orsiro stentLars Jakobsen, Evald H Christiansen, Phillip Freeman, et al.The American Journal of Cardiology|July 21, 2019
Comparison of Acute Versus Subacute Coronary Angiography in Patients With NON-ST-Elevation Myocardial Infarction (from the NONSTEMI Trial)Martin B Rasmussen, Carsten Stengaard, Jacob T Sørensen, et al.Pageof 6